Temodex/SI053 will be presented at international conferences in North and South America

Booking.com

Temodex and Double Bond Pharmaceutical’s drug candidate SI053 will be presented at “Joint Conference of the Society for Neuro-Oncology and the Society for CNS Interstitial Delivery of Therapeutics on Therapeutic Delivery to the CNS” at November 20-21th (Phoenix, Arizona) and at “VII Congreso Massin, Society of International Neurosurgeons ”November 21-23 (Cartagene, Colombia).

“I am pleased that we will present the experience with the use of Temodex and our development plans regarding SI053 to world experts in neuro-oncology on both American continents”, – comments CEO Igor Lokot

More

Booking.com

Source: Temodex/SI053 will be presented at international conferences in North and South America

Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.